Musely, a direct-to-consumer telemedicine platform, has secured over $360 million in non-dilutive capital from Basic Catalyst’s Buyer Worth Fund (CVF).
The corporate focuses on compounded therapies for pores and skin, hair, and menopause care. Musely co-founder and CEO, Jack Jia, instructed TechCrunch that when CVF buyers reached out to him final yr, he wasn’t trying to increase capital.
That’s as a result of Musely, which was based in 2014 as a wellness neighborhood earlier than pivoting to prescription skincare in 2019, has been money circulation optimistic for years, he stated. Jia didn’t need to scale back his possession within the firm by promoting off a piece of it to VCs. They continuously approached him a few potential spherical and he constantly turned them down, he stated.
However in contrast to conventional enterprise capital, CVF wasn’t trying to take an fairness stake, nor was it providing a mortgage that may carry rate of interest prices. As an alternative, CVF’s different financing is much like a tiny revenue-share settlement: corporations with predictable income streams borrow capital, after which repay the funds together with a set, capped proportion of income it generates from the usage of Basic Catalyst’s fund
Though Jia was initially skeptical, he shortly realized CVF’s phrases have been extra favorable than a typical financial institution mortgage and much less expensive than a dilutive fairness spherical.
“Once I mathematically modeled it, I discovered this totally compelling,” he stated.
Whereas Musely has been rising its income on common 50% year-over-year and has served over 1.2 million sufferers, buying new prospects for DTC manufacturers like Musely might be very pricey, Jia defined. “Once you grow to be a billion-dollar income firm, you want one other billion so as to develop to the subsequent billion,” he stated. “That’s why many of the DTC corporations, when you have a look at the capital burn, it’s large.”
Techcrunch occasion
San Francisco, CA
|
October 13-15, 2026
The funding from CVF solves this drawback, offering Musely with a capital struggle chest to help its buyer progress. The funding will help gross sales, advertising, and different buyer acquisition efforts.
Musely joins a CVF portfolio that features Grammarly, Lemonade, and Ro. The fund maintains its personal distinct restricted companions, and the capital it invests was not included in Basic Catalyst’s final $8 billion fundraise.
In contrast to lots of its friends, Musely has been remarkably capital-efficient. After elevating $20 million from DCM and different buyers in 2014, the corporate has not raised a single greenback of fairness capital since, in accordance with Jia. Musely permits sufferers to entry prescription merchandise via asynchronous consultations with board-certified dermatologists and OB-GYNs.
Once you buy via hyperlinks in our articles, we could earn a small fee. This doesn’t have an effect on our editorial independence.
